Abstract
Objective:To develop a method to evaluate the effects of clonidine and prazosin on sexual function in hypertensive women.
Design:Crossover, active-drug controlled pilot study.
Setting:Community recruitment to a university-based teaching hospital.
Patients:Ten premenopausal and eight postmenopausal women with mild hypertension and unimpaired sexual function.
Intervention:Periodic, self-administered daily diaries assessed the sexual arousal and desire and orgasmic function of women receiving placebo, clonidine, and prazosin.
Measurements and main results:Using analysis of variance for orgasmic characteristics and comparison of the percentages of yes responses to the sexual function questions, no significant difference in the levels of sexual function of women receiving placebo, clonidine, and prazosin was found. However, there was a suggestion that clonidine and prazosin affected some aspects of sexual function. Of the women who received clonidine first, fewer were receptive to partner approach during medication therapy (49%) than during placebo (61%). Fewer women wished for their partners to approach them (WISH) during therapy (41% and 53% for clonidine and prazosin, respectively) than during placebo (60%). In the group that received prazosin first, WISH was affected (32% for prazosin, 31% for clonidine, 45% for placebo). Orgasmic strength increased from 2.1 on placebo to 2.7 on clonidine (second medication), measured on a four-point Likert scale.
Conclusions:This pilot study developed a method using self-administered daily diaries for evaluating the effects of antihypertensive agents on sexual function in hypertensive women. These potential effects need to be evaluated in larger studies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Freis ED, Calabresi MI, Castle CH, et al. Veterans Administration Cooperative Study Group on Antihypertensive Agents: effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1969;202:1028–34.
1988 Joint National Committee. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1988;148:1023–38.
Helgeland A. Treatment of mild hypertension: a five-year controlled drug trial. Am J Med. 1980;69:725–32.
Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program: I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA. 1979;242:2562–71.
Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program: II. Mortality by race, sex, and age. JAMA. 1979;242:2572–7.
Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. Br Med J. 1985;291:97–104.
Haynes RB, Sackett DL, Taylor DW, Gibson ES, Johnson AL. Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med. 1978;299:741–4.
Stevenson JG, Umstead GS. Sexual dysfunction due to antihypertensive agents. Drug Intell Clin Pharm. 1984;18:113–21.
Reichgott MJ. Problems of sexual function in patients with hypertension. Cardiovasc Med. 1979;4:149–56.
Hogan MJ, Wallin JD, Baer RM. Antihypertensive therapy and male sexual dysfunction. Psychosomatics. 1980;21:234–7.
Croog SH, Levine S, Sudilovsky A, Baume RM, Clive J. Sexual symptoms in hypertensive patients: a clinical trial of antihypertensive medications. Arch Intern Med. 1988;148:788–94.
Hsueh WA. Sexual dysfunction with aging and systemic hypertension. Am J Cardiol. 1988;61:18H-23H.
Moss HB, Procci WR. Sexual dysfunction associated with oral antihypertensive medications: a critical survey of the literature. Gen Hosp Psychiatry. 1982;4:121–9.
Smith PJ, Talbert RL. Sexual dysfunction with antihypertensives and antipsychotic agents. Clin Pharm. 1986;5:373–84.
Arze RS, Ramos JM, Rashid HU, Kerr DNS. Amenorrhoea, galactorrhoea, and hyperprolactinaemia induced by methyldopa [clin res]. Br Med J. 1981;283:194.
Loriaux DL. Spironolactone and endocrine dysfunction. Ann Intern Med. 1976;85:630–6.
Onesti G, Bock KD, Heimsoth V, Kim KE, Merguet P. Clonidine: a new antihypertensive agent. Am J Cardiol. 1971;28:74–83.
Michelson EL, Frishman WH, Lewis JE, et al. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension. Am J Med. 1983;75(4A):68–80.
Lipson LG. Treatment of hypertension in diabetic men: problems with sexual dysfunction. Am J Cardiol. 1984;53:46A-50A.
Yodfat Y, Fidel J, Bloom DS. Captopril as a replacement for multiple therapy in hypertension: a controlled study. J Hypertens. 1985;3(suppl):S155-S158.
Curb JD, Borhani NO, Blaszkowski TP, Zimbaldi N, Fotice S, Williams W. Long-term surveillance for adverse effects of antihypertensive drugs. JAMA. 1985;253:3263–8.
Milliken GA, Johnson DE. Analysis of messy data volume I: designed experiments. New York: Van Nostrand Reinhold Company, 1984.
Woods JR, Williams JG, Tavel M. The two-period crossover design in medical research. Ann Intern Med. 1989;110:560–6.
Ende J, Rockwell S, Glasgow M. The sexual history in general medicine practice. Arch Intern Med. 1984;144:558–61.
Bulpitt CJ, Dollery CT, Carne S. Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J. 1976;38:121–8.
Sarrel PM. Sexuality in the middle years. Clin Obstet Gynecol. 1987;14:49–62.
Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont, CA: Life-time Learning Publications, 1982.
Author information
Authors and Affiliations
Additional information
Supported by Pfizer, Inc.
Rights and permissions
About this article
Cite this article
Hodge, R.H., Harward, M.P., West, M.S. et al. Sexual function of women taking antihypertensive agents. J Gen Intern Med 6, 290–294 (1991). https://doi.org/10.1007/BF02597423
Issue Date:
DOI: https://doi.org/10.1007/BF02597423